Erasca, Inc.

Organization

San Diego, CA, US

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Tricyclic pyridones and pyrimidones
- Patent number 11,845,761
- Issue date Dec 19, 2023
- Erasca, Inc.
- Jun Feng
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
AMIDE AND UREA-CONTAINING TRICYCLIC KRAS INHIBITORS
- Publication number 20240383921
- Publication date Nov 21, 2024
- Erasca, Inc.
- Marcos GONZALEZ-LOPEZ
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES AGAINST EGFR AND THEIR USES
- Publication number 20240383988
- Publication date Nov 21, 2024
- Erasca, Inc.
- Sachdev SIDHU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ERK1/2 AND EGFR INHIBITORS COMBINATION THERAPY
- Publication number 20240307392
- Publication date Sep 19, 2024
- Erasca, Inc.
- Robert Field SHOEMAKER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ERK1/2 AND SHP2 INHIBITORS COMBINATION THERAPY
- Publication number 20240299388
- Publication date Sep 12, 2024
- Erasca, Inc.
- Robert Field SHOEMAKER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
KRAS INHIBITOR CONJUGATES
- Publication number 20240293558
- Publication date Sep 5, 2024
- Erasca, Inc.
- Hengmiao CHENG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SHP2 AND CDK4/6 INHIBITORS COMBINATION THERAPIES FOR THE TREATMENT...
- Publication number 20240293422
- Publication date Sep 5, 2024
- Erasca, Inc.
- Leenus MARTIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ERK1/2 AND KRAS G12C INHIBITORS COMBINATION THERAPY
- Publication number 20240285625
- Publication date Aug 29, 2024
- Erasca, Inc.
- Robert Field SHOEMAKER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ERK1/2 OR SHP2 INHIBITORS AND FLT3 INHIBITORS COMBINATION THERAPY
- Publication number 20240285624
- Publication date Aug 29, 2024
- Erasca, Inc.
- Robert Field SHOEMAKER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EGFR INHIBITOR POLYMORPH FORMS
- Publication number 20240287088
- Publication date Aug 29, 2024
- Erasca, Inc.
- Jean-Michel Vernier
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USES OF HETEROCYCLIC INHIBITORS OF ERK1/2
- Publication number 20240207269
- Publication date Jun 27, 2024
- Erasca, Inc.
- Dawei XUAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TREATING CANCER
- Publication number 20240058340
- Publication date Feb 22, 2024
- The Regents of the University of California
- Jean-Michel Vernier
- G01 - MEASURING TESTING
Information Patent Application
COMBINATION THERAPIES FOR THE TREATMENT OF CANCER
- Publication number 20240058352
- Publication date Feb 22, 2024
- Erasca, Inc.
- Leenus MARTIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPIES FOR THE TREATMENT OF CANCER
- Publication number 20240050441
- Publication date Feb 15, 2024
- Erasca, Inc.
- Leenus MARTIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRICYCLIC PYRIDONES AND PYRIMIDONES
- Publication number 20230203063
- Publication date Jun 29, 2023
- Erasca, Inc.
- Jun FENG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRICYCLIC PYRIDONES AND PYRIMIDONES
- Publication number 20230159563
- Publication date May 25, 2023
- Erasca, Inc.
- Jun FENG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRICYCLIC PYRIDONES AND PYRIMIDONES
- Publication number 20230107642
- Publication date Apr 6, 2023
- Erasca, Inc.
- Jun FENG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRICYCLIC PYRIDONES AND PYRIMIDONES
- Publication number 20220119409
- Publication date Apr 21, 2022
- Erasca, Inc.
- Jun FENG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRROLIDINE-FUSED HETEROCYCLES
- Publication number 20210292330
- Publication date Sep 23, 2021
- Erasca, Inc.
- Takasuke Mukaiyama
- C07 - ORGANIC CHEMISTRY

Please log in for detailed analytics

Trademarklast 30 trademarks

Information Trademark
97939434 - SEACRAFT
- Serial number 97939434
- Filing date May 16, 2023
- Erasca, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
97939437 - SEACRAFT
- Serial number 97939437
- Filing date May 16, 2023
- Erasca, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
97281458 - ERASCA VENTURES
- Serial number 97281458
- Filing date Feb 23, 2022
- Erasca, Inc.
- 36 - Insurance
Information Trademark
97281470 - ERASCA FOUNDATION
- Serial number 97281470
- Filing date Feb 23, 2022
- Erasca, Inc.
- 36 - Insurance
Information Trademark
90527854 - MAPKLAMP
- Serial number 90527854
- Filing date Feb 12, 2021
- Erasca, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
88642063 - ERASCA
- Serial number 88642063
- Filing date Oct 4, 2019
- Erasca, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
88325560 - ERASCA
- Serial number 88325560
- Registration number 6273413
- Filing date Mar 5, 2019
- Erasca, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
88325573 - ERASCA
- Serial number 88325573
- Registration number 6273414
- Filing date Mar 5, 2019
- Erasca, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
88325575 - OPRA
- Serial number 88325575
- Filing date Mar 5, 2019
- Erasca, Inc.
- 5 - Pharmaceutical and veterinary preparations

Erasca, Inc.

Organization

Patents Grantslast 30 patents

Tricyclic pyridones and pyrimidones

Patents Applicationslast 30 patents

AMIDE AND UREA-CONTAINING TRICYCLIC KRAS INHIBITORS

ANTIBODIES AGAINST EGFR AND THEIR USES

ERK1/2 AND EGFR INHIBITORS COMBINATION THERAPY

ERK1/2 AND SHP2 INHIBITORS COMBINATION THERAPY

KRAS INHIBITOR CONJUGATES

SHP2 AND CDK4/6 INHIBITORS COMBINATION THERAPIES FOR THE TREATMENT...

ERK1/2 AND KRAS G12C INHIBITORS COMBINATION THERAPY

ERK1/2 OR SHP2 INHIBITORS AND FLT3 INHIBITORS COMBINATION THERAPY

EGFR INHIBITOR POLYMORPH FORMS

USES OF HETEROCYCLIC INHIBITORS OF ERK1/2

COMPOSITIONS AND METHODS FOR TREATING CANCER

COMBINATION THERAPIES FOR THE TREATMENT OF CANCER

COMBINATION THERAPIES FOR THE TREATMENT OF CANCER

TRICYCLIC PYRIDONES AND PYRIMIDONES

TRICYCLIC PYRIDONES AND PYRIMIDONES

TRICYCLIC PYRIDONES AND PYRIMIDONES

TRICYCLIC PYRIDONES AND PYRIMIDONES

PYRROLIDINE-FUSED HETEROCYCLES

Trademarklast 30 trademarks

97939434 - SEACRAFT

97939437 - SEACRAFT

97281458 - ERASCA VENTURES

97281470 - ERASCA FOUNDATION

90527854 - MAPKLAMP

88642063 - ERASCA

88325560 - ERASCA

88325573 - ERASCA

88325575 - OPRA